🇺🇸 FDA
Patent

US 12005054

Piperidinyl-3-(aryloxy)propanamides and propanoates

granted A61KA61K31/40A61K31/4355

Quick answer

US patent 12005054 (Piperidinyl-3-(aryloxy)propanamides and propanoates) held by Takeda Pharmaceutical Company Limited expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/40, A61K31/4355, A61K31/438, A61K31/4439